| 0 (0%) | 12-27 04:19 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 55.37 | 1-year : | 61.01 |
| Resists | First : | 47.41 | Second : | 52.24 |
| Pivot price | 43.02  |
|||
| Supports | First : | 39.59 | Second : | 32.94 |
| MAs | MA(5) : | 43.66  |
MA(20) : | 44.1 |
| MA(100) : | 37 |
MA(250) : | 0 | |
| MACD | MACD : | 0.6 |
Signal : | 0.9 |
| %K %D | K(14,3) : | 44.3 |
D(3) : | 41.3 |
| RSI | RSI(14): 53.8 |
|||
| 52-week | High : | 52.24 | Low : | 15.5 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ RIGL ] has closed below upper band by 37.3%. Bollinger Bands are 36.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 44.57 - 44.79 | 44.79 - 44.97 |
| Low: | 42.08 - 42.38 | 42.38 - 42.61 |
| Close: | 43.59 - 44.04 | 44.04 - 44.41 |
Fri, 26 Dec 2025
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Could Be 23% Below Their Intrinsic Value Estimate - 富途牛牛
Thu, 25 Dec 2025
(RIGL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Sun, 21 Dec 2025
Rigel Pharmaceuticals (NASDAQ:RIGL) Upgraded to Buy at Wall Street Zen - MarketBeat
Fri, 19 Dec 2025
Read the Arrest Affidavit - The New York Times
Fri, 05 Dec 2025
Rigel Pharmaceuticals (RIGL) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 18 (M) |
| Shares Float | 18 (M) |
| Held by Insiders | 2.6 (%) |
| Held by Institutions | 84.2 (%) |
| Shares Short | 2,760 (K) |
| Shares Short P.Month | 3,440 (K) |
| EPS | 6.19 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.48 |
| Profit Margin | 40.1 % |
| Operating Margin | 40.9 % |
| Return on Assets (ttm) | 38.9 % |
| Return on Equity (ttm) | 220 % |
| Qtrly Rev. Growth | 25.6 % |
| Gross Profit (p.s.) | 12.91 |
| Sales Per Share | 15.54 |
| EBITDA (p.s.) | 6.68 |
| Qtrly Earnings Growth | 108.5 % |
| Operating Cash Flow | 68 (M) |
| Levered Free Cash Flow | 62 (M) |
| PE Ratio | 7.1 |
| PEG Ratio | 0 |
| Price to Book value | 6.79 |
| Price to Sales | 2.83 |
| Price to Cash Flow | 11.71 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|